WallStreetZenWallStreetZen

NASDAQ: MLYS
Mineralys Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Mineralys Therapeutics earnings were -$190.8M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest MLYS earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$43.3M, up 2.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MLYS reported annual earnings of -$177.8M, with 147.3% growth. The next MLYS earnings date is Nov 11, 2025.

MLYS earnings history

Current Revenue
$0.0
Current Earnings
-$190.8M
Current Profit Margin
0%

MLYS Return on Equity

Current Company
-70.4%
Current Industry
-10%
Current Market
30.7%
MLYS's Return on Equity (-70.4%)... subscribe to Premium to read more.
High Return on Equity Performance

MLYS undefined

Current Company
-65.5%
Current Industry
-0.2%
MLYS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MLYS announces earnings.

MLYS undefined

Current Company
-60.84%
Current Industry
6.4%

MLYS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MLYS-$190.72M-$190.77MN/A-$3.56
IBRX-$208.99M-$367.09MN/A-$0.44
FOLD$33.06M-$38.10MN/A-$0.12
CPRX$310.08M$208.67M+34.03%$1.73
VCYT$63.03M$33.05MN/A$0.43
View Top Biotech Stocks

MLYS earnings dates

Next earnings date
Nov 11, 2025

Mineralys Therapeutics Earnings Reports & History FAQ

What were Mineralys Therapeutics's earnings last quarter?

On MLYS's earnings call on Invalid Date, Mineralys Therapeutics (NASDAQ: MLYS) reported Q2 2025 earnings per share (EPS) of -$0.66, up 20.48% year over year. Total MLYS earnings for the quarter were -$43.27 million. In the same quarter last year, Mineralys Therapeutics's earnings per share (EPS) was -$0.83.

If you're new to stock investing, here's how to buy Mineralys Therapeutics stock.

When does Mineralys Therapeutics report earnings?

The next MLYS earnings date is Invalid Date. Add MLYS to your watchlist to be reminded of Mineralys Therapeutics's next earnings date.

Is Mineralys Therapeutics profitable or losing money?

As of the last Mineralys Therapeutics earnings report, Mineralys Therapeutics is currently losing money. Mineralys Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$190.77 million, a 59.41% increase year over year.

What was MLYS's earnings growth in the past year?

As of Mineralys Therapeutics's earnings date in Invalid Date, Mineralys Therapeutics's earnings has grown year over year. MLYS earnings in the past year totalled -$190.77 million.

What are Mineralys Therapeutics's earnings expectations?

The current EPS estimate for Mineralys Therapeutics's earnings report in Invalid Date is -$0.64.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.